Intellia Therapeutics Inc Stock Forecast
Intellia Therapeutics Inc stock downgraded from Hold/Accumulate to Sell Candidate after Wednesday trading session.
(Updated on Jul 03, 2024)
The Intellia Therapeutics Inc stock price gained 3.61% on the last trading day (Wednesday, 3rd Jul 2024), rising from $22.15 to $22.95. During the last trading day the stock fluctuated 4.51% from a day low at $22.15 to a day high of $23.15. The price has been going up and down for this period, and there has been a -7.46% loss for the last 2 weeks. Volume fell on the last day by -561 thousand shares and in total, 839 thousand shares were bought and sold for approximately $19.25 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Intellia Therapeutics Inc stock with a 90% probability to be traded between $20.81 and $26.99 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NTLA Signals & Forecast
Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Intellia Therapeutics Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $24.07. On a fall, the stock will find some support from the short-term average at $22.86. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, June 13, 2024, and so far it has fallen -11.59%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Intellia Therapeutics Inc stock
Intellia Therapeutics Inc finds support from accumulated volume at $22.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.00 between high and low, or 4.51%. For the last week, the stock has had daily average volatility of 4.93%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NTLA) For The Upcoming Trading Day Of Friday 5th
For the upcoming trading day on Friday, 5th we expect Intellia Therapeutics Inc to open at $22.75, and during the day (based on 14 day Average True Range), to move between $21.69 and $24.21, which gives a possible trading interval of +/-$1.26 (+/-5.50%) up or down from last closing price. If Intellia Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 10.99% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $22.91 (0.17%) than the resistance at $23.09 (0.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Intellia Therapeutics Inc stock A Buy?
Intellia Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -1.826 Sell Candidate Downgraded
Predicted Opening Price for Intellia Therapeutics Inc of Friday, July 5, 2024
| Fair opening price July 5, 2024 | Current price |
|---|---|
| $22.75 ( 0.87%) | $22.95 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NTLA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 23.75 | 3.49% |
| R2 | 23.37 | 1.82% |
| R1 | 23.13 | 0.793% |
| Price | 22.95 | |
| S1 | 22.37 | -2.54% |
| S2 | 22.13 | -3.56% |
| S3 | 21.75 | -5.23% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 25.00 | 8.93% |
| R2 | 23.52 | 2.48% |
| R1 | 23.09 | 0.610% |
| Price | 22.95 | |
| S1 | 22.91 | -0.174% |
| S2 | 22.38 | -2.48% |
| S3 | 21.67 | -5.58% |
FAQ
Click here for our free guide on how to buy Intellia Therapeutics Inc Stock.
